Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hunter

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
Plos One|January 21, 2015
Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmissionAnatoli Kamali, Matt A Price, Shabir Lakhi, et al.
Science Translational Medicine|November 22, 2019
Strong T<sub>H</sub>1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacyVenkateswarlu Chamcha, Pradeep B J Reddy, Sunil Kannanganat, et al.
Science (New York, N.Y.)|January 17, 2004
Public health. A sound rationale needed for phase III HIV-1 vaccine trialsDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2015
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progressionDaniel T Claiborne, Jessica L Prince, Eileen Scully, et al.
Virology|November 6, 2012
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clonesJoshua Baalwa, Shuyi Wang, Nicholas F Parrish, et al.
International Journal of Epidemiology|September 4, 2020
Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discoveryMatt A Price, William Kilembe, Eugene Ruzagira, et al.
Journal of Virology|December 9, 2016
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive MacaquesSudhir Pai Kasturi, Pamela A Kozlowski, Helder I Nakaya, et al.
Science (New York, N.Y.)|July 12, 2014
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneckJonathan M Carlson, Malinda Schaefer, Daniela C Monaco, et al.
JCI Insight|March 5, 2019
Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaquesCaroline Petitdemange, Sudhir Pai Kasturi, Pamela A Kozlowski, et al.
Journal of Virology|September 15, 2006
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern AfricaMing Li, Jesus F Salazar-Gonzalez, Cynthia A Derdeyn, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Plos One|January 21, 2015
Creating an African HIV clinical research and prevention trials network: HIV prevalence, incidence and transmissionAnatoli Kamali, Matt A Price, Shabir Lakhi, et al.
Science Translational Medicine|November 22, 2019
Strong T<sub>H</sub>1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacyVenkateswarlu Chamcha, Pradeep B J Reddy, Sunil Kannanganat, et al.
Science (New York, N.Y.)|January 17, 2004
Public health. A sound rationale needed for phase III HIV-1 vaccine trialsDennis R Burton, Ronald C Desrosiers, Robert W Doms, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2015
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progressionDaniel T Claiborne, Jessica L Prince, Eileen Scully, et al.
Virology|November 6, 2012
Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clonesJoshua Baalwa, Shuyi Wang, Nicholas F Parrish, et al.
International Journal of Epidemiology|September 4, 2020
Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discoveryMatt A Price, William Kilembe, Eugene Ruzagira, et al.
Journal of Virology|December 9, 2016
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive MacaquesSudhir Pai Kasturi, Pamela A Kozlowski, Helder I Nakaya, et al.
Science (New York, N.Y.)|July 12, 2014
HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneckJonathan M Carlson, Malinda Schaefer, Daniela C Monaco, et al.
JCI Insight|March 5, 2019
Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaquesCaroline Petitdemange, Sudhir Pai Kasturi, Pamela A Kozlowski, et al.
Journal of Virology|September 15, 2006
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern AfricaMing Li, Jesus F Salazar-Gonzalez, Cynthia A Derdeyn, et al.
Pageof 22